Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil
Authors:
- Awesh K. YadavAYAwesh K. Yadav
- Abhinav AgarwalAAAbhinav Agarwal
- Gopal RaiGRGopal Rai
- Pradeep MishraPMPradeep Mishra
- Sanyog JainSJSanyog Jain
- Anil K. MishraAMAnil K. Mishra
- Himanshu AgrawalHAHimanshu Agrawal
- Govind P. AgrawalGAGovind P. Agrawal
- 26 August 2010
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 17 (8) , 561-572
Abstract
The present investigation was aimed to develop and explore the prospective of engineered PLGA nanoparticles as vehicles for targeted delivery of 5-fluorouracil (5-FU). Nanoparticles of 5-FU-loaded hyaluronic acid-poly(ethylene glycol)-poly(lactide-co-glycolide) (HA-PEG-PLGA-FU) copolymer were prepared and characterized by FTIR, NMR, transmission electron microscopy, particle size analysis, DSC, and X-ray diffractometer measurement studies. The nanoparticulate formulation was evaluated for in vitro release, hemolytic toxicity, and hematological toxicity. Cytotoxicity studies were performed on Ehrlich ascites tumor (EAT) cell lines using MTT cell proliferation assay. Biodistribution studies of 99mTc labeled formulation were conducted on EAT-bearing mice. The in vivo tumor inhibition study was also performed after i.v. administration of HA-PEG-PLGA-FU nanoparticles. The HA conjugated formulation was found to be less hemolytic but more cytotoxic as compared to free drug. The hematological data suggested that HA-PEG-PLGA-FU formulation was less immunogenic compared to plain drug. The tissue distribution studies displayed that HA-PEG-PLGA-FU were able to deliver a higher concentration of 5-FU in the tumor mass. In addition, the HA-PEG-PLGA-FU nanoparticles reduced tumor volume significantly in comparison with 5-FU. Thus, it was concluded that the conjugation of HA imparts targetability to the formulation, and enhanced permeation and retention effect ruled out its access to the non-tumor tissues, at the same time favored selective entry in tumors, thereby reducing the side-effects both in vitro and in vivo.Keywords
This publication has 47 references indexed in Scilit:
- Synthesis and Characterization of mPEG−PLA Prodrug MicellesBiomacromolecules, 2005
- Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugsBiomaterials, 2005
- In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel deliveryInternational Journal of Pharmaceutics, 2005
- cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin DeliveryAngewandte Chemie International Edition, 2004
- Poly(d,l-lactide-ran-ε-caprolactone)-poly(ethylene glycol)-poly(d,l-lactide-ran-ε-caprolactone) as parenteral drug-delivery systemsBiomaterials, 2004
- Receptor induction and targeted drug delivery: a new antileukaemia strategyExpert Opinion on Biological Therapy, 2003
- CD44 in CancerCritical Reviews in Clinical Laboratory Sciences, 2002
- Thermoanalysis of microspheresThermochimica Acta, 1995
- The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.Journal of Cell Biology, 1992
- Effect of liposome surface charge on the stability of technetium (99mTc) radiolabelled liposomesJournal of Microencapsulation, 1989